LINC00668: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Target Name: LINC00668

NCBI ID: G400643

LINC00668

Other Name(s): long intergenic non-protein coding RNA 668 | Long intergenic non-protein coding RNA 668

LINC00668: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Introduction

LINC00668 is a long non-coding RNA (lncRNA) molecule that has been identified in various organisms, including humans. It is characterized by its unique 29 base pair length and its absence of protein coding sequences. LINC00668 is expressed in various cell types of the human body and has been associated with various cellular processes, including cell adhesion, migration, and pluripotency.

Drug Targeting

LINC00668 has been identified as a potential drug target due to its unique structure and its involvement in various cellular processes. Several studies have shown that LINC00668 can interact with various proteins, including the protein known as PDGF-BB. These interactions suggest that LINC00668 may play a role in the regulation of cellular processes, including cell growth, differentiation, and survival.

One potential mechanism by which LINC00668 may be a drug target is its role in the regulation of cell adhesion. Adhesion is a critical process that allows cells to stick together and form tissues. LINC00668 has been shown to play a role in the regulation of cell- cell adhesion by interacting with the protein known as E-cadherin.

Another potential mechanism by which LINC00668 may be a drug target is its role in the regulation of cell migration. Migration is a critical process that allows cells to move towards new environments and to form tissues. LINC00668 has been shown to play a role in the regulation of cell migration by interacting with the protein known as Src1.

Biomarker

LINC00668 has also been identified as a potential biomarker for various diseases. The lack of protein coding sequences in LINC00668 makes it resistant to most RNA-based assays, including PCR and qRT-PCR. This resistance makes LINC00668 an ideal candidate for use as a biomarker in diseases that are difficult to diagnose or treat using traditional biological methods.

For example, LINC00668 can be used to detect cancer because its expression levels increase with tumor size. Additionally, LINC00668 could be used to detect neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, as they are often associated with neuronal death and synaptic damage.

Conclusion

LINC00668 is a long non-coding RNA molecule that has been identified in various organisms, including humans. Its unique structure and its involvement in various cellular processes make it a potential drug target and biomarker. Further studies are needed to fully understand the role of LINC00668 in cellular processes and its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 668

The "LINC00668 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00668 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets